VeriMomdibromopropamidine diisethionate est-il sûr pendant la grossesse ?
No harmonised CLP classification or SCCS/CIR safety assessment was found for dibromopropamidine diisethionate (CAS 614-87-9); no reproductive or developmental toxicity studies for this substance were located in PubMed. The substance is used topically (ophthalmic/antiseptic formulations at ~0.15%), so systemic exposure from typical topical/ophthalmic use is expected to be low but measurable. Sources: ECHA substance page, PubChem, product/pharmacopoeia listings showing topical/ophthalmic use.
Related ingredients
Frequently asked questions
- dibromopropamidine diisethionate est-il sûr pendant la grossesse ?
- No harmonised CLP classification or SCCS/CIR safety assessment was found for dibromopropamidine diisethionate (CAS 614-87-9); no reproductive or developmental toxicity studies for this substance were located in PubMed. The substance is used topically (ophthalmic/antiseptic formulations at ~0.15%), so systemic exposure from typical topical/ophthalmic use is expected to be low but measurable. Sources: ECHA substance page, PubChem, product/pharmacopoeia listings showing topical/ophthalmic use.
- dibromopropamidine diisethionate est-il sûr pendant l'allaitement ?
- No evidence of reproductive or developmental hazard or mechanism specific to this compound was found. Because topical/ophthalmic use leads to low but measurable systemic exposure, a low exposure score is assigned for lactation; no data on milk transfer were located. Sources: PubChem entry, product/labeling references indicating topical ophthalmic use; no PubMed studies on lactation or milk transfer were found.
- dibromopropamidine diisethionate est-il sûr pour la peau de bébé ?
- No infant-specific reproductive or mechanistic evidence was found. The ingredient is used in topical/ophthalmic products (including products for children in some markets), and immature infant skin has higher per‑kg exposure; therefore exposure is scored one category higher than adult topical use. No data were found showing increased hazard or specific infant toxicity. Sources: product/medicinal listings showing pediatric topical/ophthalmic use and pharmacopoeial references; absence of reproductive/toxicity studies in PubMed.
- Comment VeriMom évalue-t-il dibromopropamidine diisethionate ?
- VeriMom évalue dibromopropamidine diisethionate à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à dibromopropamidine diisethionate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à dibromopropamidine diisethionate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.